Vistin Pharma ASA: Annual Report for 2021
27 4월 2022 - 8:00PM
Vistin Pharma ASA: Annual Report for 2021
Oslo, Norway, 27 April 2022
Please find attached the Annual Report for 2021 for Vistin
Pharma ASA. There are no material changes in the financial
statements compared to the preliminary full year result
presented on 17 February 2022.
The annual report for 2021 will also be made available on
www.vistin.com.
This information is subject to the disclosure requirements
pursuant to Section 5-12 the Norwegian Securities Trading Act
*****
For further information, please contact:
Alexander KarlsenCFO+47 97 05 36
21Alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing
Metformin Hydrochloride (API). The Metformin is also available as
Direct Compressible lubricated granules. As a solely dedicated
European Metformin producer, Vistin Pharma is a
well-positioned supplier to leading pharmaceutical companies.
Vistin Pharma is headquartered in Oslo, Norway, and has highly
qualified employees and a dedicated manufacturing facility in
Kragerø.
- Annual Report 2021 for Vistin Pharma ASA
- Vistinpharmaasa-2021-12-31-en
Vistin Pharma Asa (LSE:0RAM)
과거 데이터 주식 차트
부터 3월(3) 2025 으로 4월(4) 2025
Vistin Pharma Asa (LSE:0RAM)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 4월(4) 2025
